These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14667263)

  • 1. Drug-eluting stents. A review of the current literature.
    Laroia ST; Laroia AT
    Cardiol Rev; 2004; 12(1):37-43. PubMed ID: 14667263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting stents: preventing restenosis.
    Slavin L; Chhabra A; Tobis JM
    Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents.
    Iijima R; Mehilli J; Schömig A; Kastrati A
    Minerva Cardioangiol; 2006 Oct; 54(5):539-55. PubMed ID: 17019392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting stents: the panacea for restenosis?
    Lim MC
    Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
    [No Abstract]   [Full Text] [Related]  

  • 6. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
    Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A
    J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A stent is not just a stent: Stent construction and design do matter in its clinical performance.
    Lau KW; Johan A; Sigwart U; Hung JS
    Singapore Med J; 2004 Jul; 45(7):305-11; quiz 312. PubMed ID: 15221045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stents: from randomized trials to the real world.
    Saia F; Degertekin M; Lemos PA; Serruys PW
    Minerva Cardioangiol; 2004 Oct; 52(5):349-63. PubMed ID: 15514571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release profiles in drug-eluting stents: issues and uncertainties.
    Venkatraman S; Boey F
    J Control Release; 2007 Jul; 120(3):149-60. PubMed ID: 17582635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.
    Nordmann AJ; Briel M; Bucher HC
    Eur Heart J; 2006 Dec; 27(23):2784-814. PubMed ID: 17020889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
    Elezi S; Dibra A; Folkerts U; Mehilli J; Heigl S; Schömig A; Kastrati A
    J Am Coll Cardiol; 2006 Jul; 48(2):262-7. PubMed ID: 16843172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early experiences and clinical implications of restenosis and drug-eluting stents: Part 2.
    Chong PH; Cheng JW
    Ann Pharmacother; 2004 May; 38(5):845-52. PubMed ID: 15039482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
    Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
    Chu WW; Kuchulakanti PK; Torguson R; Wang B; Clavijo LC; Suddath WO; Pichard AD; Satler LF; Kent KM; Waksman R
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):62-6. PubMed ID: 16755592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation drug-eluting coronary stents.
    Lange RA; Hillis LD
    N Engl J Med; 2010 May; 362(18):1728-30. PubMed ID: 20445185
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials.
    Halkin A; Stone GW
    J Interv Cardiol; 2004 Oct; 17(5):271-82. PubMed ID: 15491330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on drug-eluting coronary stents.
    Kipshidze NN; Tsapenko MV; Leon MB; Stone GW; Moses JW
    Expert Rev Cardiovasc Ther; 2005 Sep; 3(5):953-68. PubMed ID: 16181039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should degenerated saphenous vein grafts routinely be sealed with drug-eluting stents?
    Vermeersch P; Agostoni P
    J Interv Cardiol; 2005 Dec; 18(6):467-73. PubMed ID: 16336427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is diabetes a leveler of efficacy of DES types?
    Kastrati A
    Catheter Cardiovasc Interv; 2010 Feb; 75(3):335-7. PubMed ID: 20162698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.